Cargando…

DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer

Potentiating anti-tumor immunity by inducing tumor inflammation and T cell-mediated responses are a promising area of cancer therapy. Immunomodulatory agents that promote these effects function via a wide variety of mechanisms, including upregulation of antigen presentation pathways. Here, we show t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Na, Nixon, Mellissa J., Gonzalez-Ericsson, Paula I., Sanchez, Violeta, Opalenik, Susan R., Li, Huili, Zahnow, Cynthia A., Nickels, Michael L., Liu, Fei, Tantawy, Mohammed N., Sanders, Melinda E., Manning, H. Charles, Balko, Justin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770411/ https://www.ncbi.nlm.nih.gov/pubmed/29339738 http://dx.doi.org/10.1038/s41467-017-02630-w

Ejemplares similares

Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer
por: Hanna, Ann, et al.
Publicado: (2022)

Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2
por: Luo, Na, et al.
Publicado: (2018)

Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance
por: James, Jamaal L, et al.
Publicado: (2023)

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
por: Johnson, Douglas B., et al.
Publicado: (2016)

Mechanisms of MHC-I Downregulation and Role in Immunotherapy Response
por: Taylor, Brandie C., et al.
Publicado: (2022)

Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes
Publicado: (1989)

Tumor-Associated Lymphatics Upregulate MHC-II to Suppress Tumor-Infiltrating Lymphocytes
por: Li, Claire Y., et al.
Publicado: (2022)

MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC
por: Franklin, Derek A., et al.
Publicado: (2020)

Therapeutic potential of DNA methyltransferase inhibitors with immune checkpoint inhibitor therapy in breast cancer
por: Luo, Na, et al.
Publicado: (2018)

LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis
por: Li, Huili, et al.
Publicado: (2011)

An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes
Publicado: (1988)

PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer
por: Nixon, Mellissa J., et al.
Publicado: (2019)

Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection. Protection by T cells is MHC- restricted and MHC-regulated; a model for MHC-disease associations
Publicado: (1986)

Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities
por: Garcia, Victor, et al.
Publicado: (2015)

MEK inhibition activates STAT signaling to increase breast cancer immunogenicity via MHC-I expression
por: Franklin, Derek A., et al.
Publicado: (2020)

PBRM1 and the glycosylphosphatidylinositol biosynthetic pathway promote tumor killing mediated by MHC-unrestricted cytotoxic lymphocytes
por: Menasche, Bridget L., et al.
Publicado: (2020)

What Function Is Served By MHC Upregulation in Neural Cells?
por: Lampson, L. A., et al.
Publicado: (1992)

Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity
por: Zebertavage, Lauren K., et al.
Publicado: (2020)

Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles
Publicado: (1988)

Migration of cytotoxic lymphocytes in cell cycle permits local MHC I–dependent control of division at sites of viral infection
por: Kang, Silvia S., et al.
Publicado: (2011)

Transcriptional Reprogramming of Mature CD4(+) T helper Cells generates distinct MHC class II-restricted Cytotoxic T Lymphocytes
por: Mucida, Daniel, et al.
Publicado: (2013)

A transgenic mouse model to assess the interaction of cytotoxic T lymphocytes with virally infected, class I MHC-expressing astrocytes
por: Rall, Glenn F., et al.
Publicado: (1994)

Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer
por: Gonzalez-Ericsson, Paula I., et al.
Publicado: (2021)

Allogeneic Lymphocyte Transfer in MHC-Identical Siblings and MHC-Identical Unrelated Mauritian Cynomolgus Macaques
por: Mee, Edward T., et al.
Publicado: (2014)

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
por: Li, Huili, et al.
Publicado: (2014)

Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing’s Sarcoma, Enhancing T Cell Cytotoxicity
por: Biele, Emilie, et al.
Publicado: (2021)

CCAAT/enhancer binding proteins in normal mammary development and breast cancer
por: Zahnow, Cynthia A
Publicado: (2002)

Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells
por: Sun, Ting, et al.
Publicado: (2019)

A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis
por: Chen, Qian, et al.
Publicado: (2014)

Allogeneic Lymphocytes Persist and Traffic in Feral MHC-Matched Mauritian Cynomolgus Macaques
por: Greene, Justin M., et al.
Publicado: (2008)

Protein arginine methyltransferase 1 (PRMT1) represses MHC II transcription in macrophages by methylating CIITA
por: Fan, Zhiwen, et al.
Publicado: (2017)

Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE
por: Marín, Nieves, et al.
Publicado: (2014)

Use of “one-pot, mix-and-read” peptide-MHC class I tetramers and predictive algorithms to improve detection of cytotoxic T lymphocyte responses in cattle
por: Svitek, Nicholas, et al.
Publicado: (2014)

Cytotoxic T lymphocytes from cattle sharing the same MHC class I haplotype and immunized with live Theileria parva sporozoites differ in antigenic specificity
por: Steinaa, Lucilla, et al.
Publicado: (2018)

Methylation of the Claudin 1 Promoter Is Associated with Loss of Expression in Estrogen Receptor Positive Breast Cancer
por: Di Cello, Francescopaolo, et al.
Publicado: (2013)

Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth
por: Turner, Taylor B, et al.
Publicado: (2017)

Hsp70 Interacts with the TREM-1 Receptor Expressed on Monocytes and Thereby Stimulates Generation of Cytotoxic Lymphocytes Active against MHC-Negative Tumor Cells
por: Sharapova, Tatiana N., et al.
Publicado: (2021)

Class II MHC Self-Antigen Presentation in Human B and T Lymphocytes
por: Costantino, Cristina Maria, et al.
Publicado: (2012)

Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
por: Willimsky, Gerald, et al.
Publicado: (2008)

Recipients with In Utero Induction of Tolerance Upregulated MHC Class I in the Engrafted Donor Skin
por: Chen, Jeng-Chang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_13rk4jbgl5ah0gp1sgshjg75hd